Icon Advisers’s BioTelemetry, Inc. BEAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-99,895
Closed -$4.5M 345
2018
Q2
$4.5M Sell
99,895
-47,600
-32% -$1.9M 0.34% 82
2018
Q1
$4.58M Sell
147,495
-27,402
-16% -$901K 0.35% 86
2017
Q4
$5.23M Buy
174,897
+28,300
+19% +$819K 0.36% 83
2017
Q3
$4.84M Buy
146,597
+33,319
+29% +$1.15M 0.34% 101
2017
Q2
$3.79M Buy
113,278
+26,891
+31% +$802K 0.26% 120
2017
Q1
$2.5M Sell
86,387
-59,675
-41% -$1.48M 0.17% 169
2016
Q4
$3.26M Buy
146,062
+2,570
+2% +$50.2K 0.22% 144
2016
Q3
$2.67M Sell
143,492
-86,754
-38% -$1.64M 0.18% 173
2016
Q2
$3.75M Sell
230,246
-104,000
-31% -$1.53M 0.25% 134
2016
Q1
$3.9M Sell
334,246
-59,788
-15% -$668K 0.28% 129
2015
Q4
$4.6M Buy
394,034
+61,611
+19% +$780K 0.32% 114
2015
Q3
$4.07M Buy
332,423
+240,870
+263% +$3.07M 0.28% 122
2015
Q2
$863K Buy
91,553
+33,000
+56% +$305K 0.05% 237
2015
Q1
$518K Buy
+58,553
New +$592K 0.03% 300

Other funds holding BEAT

Icon Advisers's BEAT Position: Q3 2018 in Review

Icon Advisers sold out of BioTelemetry, Inc. (BEAT) in Q3 2018, closing a stake of 99,895 shares — an estimated $4.5M sold.

Icon Advisers first reported a position in BEAT in Q1 2015 and held it in 14 quarters. The position peaked at $5.23M in Q4 2017. 256 funds tracked by Wall St. Rank hold BEAT as of Q3 2018.

  • Icon Advisers reported no remaining BioTelemetry, Inc. position as of Q3 2018 after selling out during the quarter.
  • Icon Advisers sold 99,895 BioTelemetry, Inc. shares in Q3 2018, an estimated $4.5M.
  • Icon Advisers first reported a position in BioTelemetry, Inc. in Q1 2015 and held it in 14 quarters.
  • Icon Advisers's BioTelemetry, Inc. position peaked at $5.23M in Q4 2017.
  • 256 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q3 2018.

Based on Icon Advisers's 13F filing for Q3 2018, filed 5 Nov 2018.